These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2453793)

  • 1. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives.
    Carreno MP; Labarre D; Jozefowicz M; Kazatchkine MD
    Mol Immunol; 1988 Feb; 25(2):165-71. PubMed ID: 2453793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the complement system by polysaccharidic surfaces bearing carboxymethyl, carboxymethylbenzylamide and carboxymethylbenzylamide sulphonate groups.
    Toufik J; Carreno MP; Jozefowicz M; Labarre D
    Biomaterials; 1995 Sep; 16(13):993-1002. PubMed ID: 8580263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
    Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
    Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution.
    Toufik J; Labarre D
    Biomaterials; 1995 Sep; 16(14):1081-8. PubMed ID: 8519929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position.
    Seifert PS; Kazatchkine MD
    Mol Immunol; 1987 Dec; 24(12):1303-8. PubMed ID: 3431552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum.
    Carreno MP; Maillet F; Labarre D; Jozefowicz M; Kazatchkine MD
    Biomaterials; 1988 Nov; 9(6):514-8. PubMed ID: 2465029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum.
    Montdargent B; Toufik J; Carreno MP; Labarre D; Jozefowicz M
    Biomaterials; 1992; 13(9):571-6. PubMed ID: 1382638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of substituted dextran derivative on complement activation in vivo.
    Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD
    Biomaterials; 1995 Oct; 16(15):1163-7. PubMed ID: 8562793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of functionalized polystyrene derivatives with the complement system in human serum.
    Montdargent B; Labarre D; Jozefowicz M
    J Biomater Sci Polym Ed; 1991; 2(1):25-35. PubMed ID: 1863575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertase.
    Strunk RC; Webster RO
    Mol Immunol; 1985 Jan; 22(1):37-43. PubMed ID: 3871899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomedical polymers differ in their capacity to activate complement.
    Janatova J; Cheung AK; Parker CJ
    Complement Inflamm; 1991; 8(2):61-9. PubMed ID: 2055009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
    Dawson P; Turner MW; Bradshaw A; Westaby S
    Br J Radiol; 1983 Jul; 56(667):447-8. PubMed ID: 6602640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK; Chenoweth DE; Otsuka D; Henderson LW
    Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces.
    Montdargent B; Maillet F; Carreno MP; Jozefowicz M; Kazatchkine M; Labarre D
    Biomaterials; 1993 Feb; 14(3):203-8. PubMed ID: 8476993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation during blood donation.
    Morse AN; Churchill WH; Moore FD
    Transplant Proc; 1988 Dec; 20(6):1175-8. PubMed ID: 2974199
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement activation and endotoxin in sepsis.
    Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
    Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mechanism of PMN activation. II. By triggering the alternative pathway of complement activation.
    Müller J; Botzenhardt U; Lemmel EM
    Blut; 1982 Jul; 45(1):13-22. PubMed ID: 6177367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.